Colorectal Cancer
📧 Sign up to get email alerts when something new happens for Colorectal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation [Phase 3]
Phase 3 trial evaluating sotorasib plus panitumumab and FOLFIRI versus FOLFIRI with or without bevacizumab-awwb as first-line therapy for me…
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Natural Killer Cells and Bortezomib to Treat Cancer [Phase 1]
This Phase 1 clinical trial update reports on the combination of natural killer cells and bortezomib for several cancers, and the study has …
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Phase I Multicentre Randomized Double-Blind Parallel-Controlled Study of HLX05-N vs. ERBITUX® in Metastatic Colorectal Cancer [Phase 1]
A Phase I multicentre randomized double-blind study comparing HLX05-N to Erbitux (cetuximab) in metastatic colorectal cancer; the trial is n…
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon Cancer [NA]
A completed clinical trial evaluated health education materials with or without a physical activity program for patients treated for high-ri…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers [Phase 1]
A Phase 1 clinical trial is evaluating the addition of ZEN003694 to the standard chemotherapy capecitabine for metastatic or unresectable co…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Evaluation for NCI Surgery Branch Clinical Research Protocols
NCI's Surgery Branch Clinical Research Protocols are currently recruiting for multiple cancer studies, including synovial sarcoma, melanoma,…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Natural History Study of Early Life Exposures in Agriculture (ELEA)
An update on the ELEA natural history study sponsored by the National Cancer Institute investigating how early life exposures in agriculture…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03) [Phase 3]
Phase 3 clinical trial evaluating Precemtabart Tocentecan with or without Bevacizumab versus Trifluridine/Tipiracil plus Bevacizumab in prev…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: BAL/BOT/agenT-797 in pMMR CRC With Liver Metastases [Phase 2]
Phase 2 clinical trial update evaluating BAL, BOT, and agenT-797 in metastatic colorectal cancer with liver metastases; recruitment has not …
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Personalized Peptide Vaccine in Treating Patients With Advanced Pancreatic Cancer or Colorectal Cancer [Phase 1]
A Phase 1 clinical trial evaluating a Personalized Peptide Vaccine for advanced colorectal cancer and pancreatic cancer is currently recruit…
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers [Phase 1]
A Phase I trial evaluating [177Lu]Lu-NNS309, a radiopharmaceutical, in multiple advanced cancers including pancreatic ductal adenocarcinoma,…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Cancer Awareness Among Syrian Migrants [NA]
A clinical trial update from Toros University notes a study to raise awareness about cancer and promote screening for breast, cervical, and …
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer
A clinical trial exploring exogenous and endogenous risk factors for early-onset colorectal cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Low-dose Immunotherapy in Metastatic and Locally Advanced Colorectal and Gastric MSI/dMMR Cancers [Phase 2]
Phase 2 clinical trial evaluating low-dose immunotherapy for metastatic and locally advanced colorectal and gastric MSI/dMMR cancers; curren…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer [Phase 2]
Phase 2 clinical trial update evaluating second-line FOLFIRI with Bevacizumab, with or without Pelareorep, for Ras-mutated, microsatellite-s…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Chinese Participants With Stage IV Colorectal Cancer (MK-3475-C66) [Phase 3]
A Phase 3 trial evaluating pembrolizumab versus chemotherapy in Chinese participants with stage IV colorectal cancer (MK-3475-C66) is curren…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors [Phase 1]
Phase 1 clinical trial update for Metarrestin (ML-246) in subjects with metastatic solid tumors; the study is currently recruiting across mu…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: COLON-IM : Microbiota and Immune Infiltrate in Normal, Dysplastic and Neoplastic Colorectal Tissue
This ongoing clinical trial investigates microbiota and immune infiltrates in normal, dysplastic, and neoplastic colorectal tissue and is cu…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Decision Aid Website in Helping to Make Decisions About Fertility in Participants With Cancer [NA]
This clinical trial update notes an ongoing study at MD Anderson Cancer Center evaluating a decision aid website to help cancer patients mak…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Comparison of Expression of Carcinogenesis-related Molecular Markers in the Patients With Colon Cancer and Polyp
An observational study comparing expression of carcinogenesis-related molecular markers in patients with colorectal cancer and colorectal ad…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies [Phase 1]
A Phase 1 clinical trial evaluating KQB365 as monotherapy and in combination for advanced solid malignancies, including colorectal cancer, i…
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Vemurafenib, Cetuximab, and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or That Cannot Be Removed by Surgery [Phase 1]
Phase 1 trial evaluating a three-drug regimen (vemurafenib, cetuximab, and irinotecan hydrochloride) in patients with metastatic or unresect…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Prospective Study to Evaluate the Performance of a Real-time System in the Estimation of Colorectal Polyp Size [NA]
This clinical trial update describes a prospective study to evaluate the performance of a real-time system in estimating colorectal polyp si…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors [Phase 1, Phase 2]
Ongoing Phase 1/2 clinical trials evaluating elironrasib and daraxonrasib as solo therapies and in combination for advanced KRAS G12C-mutant…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Dual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2) Knock Out (KO) Therapy For Colorectal Cancer-Related Peritoneal Carcinomatosis: A Phase 1/2 Trial ("Chip-CRC Trial") [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating dual intraperitoneal and intravenous TROP2-directed CAR-NK cells with TGFBR2 knockout for colorectal c…